Trasplante de células progenitoras hematopoyéticas como tratamiento de rescate en pacientes con linfomas no hodgkinianos agresivos
Reyes Arranz, Guillermo Pérez(Hospital Universitario Severo Ochoa), Agustín Acevedo(Consejo Nacional de Investigaciones Científicas y Técnicas), Carmen Martínez Chamorro(Hospital Universitario de La Princesa), José Ma Fernández Rañada.(Hospital Universitario de La Princesa), Francisco J. Pajuelo(Hospital Universitario de La Princesa), César Sanz-Rodrı́guez(Merck Biopharma Co., Ltd. (Japan))
Cited by 2
Related Papers
Vorinostat in solid and hematologic malignancies
|Journal of Hematology & Oncology|2009|204
Chronic depolarization prevents programmed death of sympathetic neurons in vitro but does not support growth: requirement for Ca2+ influx but not Trk activation
|Journal of Neuroscience|1995|170
Primary hepatic lymphoma
|Cancer|2001|157
Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study
|Critical Care|2006|128
Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma
|Clinical Lymphoma & Myeloma|2009|97